Dr. Tin-U is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1350 First Colony Blvd
Sugar Land, TX 77479Phone+1 281-277-5200Fax+1 281-277-7295
Summary
- Dr. Caesar Tin-U is an oncologist in Sugar Land, TX and is affiliated with multiple hospitals in the area, including Houston Methodist Hospital, Memorial Hermann Southwest Hospital, Memorial Hermann Sugar Land Hospital, Houston Methodist Sugar Land Hospital, St. Luke's Sugar Land Hospital, and Baylor St. Luke's Medical Center. He received his medical degree from University Institute of Medicine 1 and has been in practice 32 years. He specializes in breast cancer, gastrointestinal cancer, hiv/aids related, and hematologic oncology and is experienced in amyloidosis, hematologic oncology, breast cancer, myelodysplasia, and myelofibrosis.
Education & Training
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 1996 - 1999
- Graduate HospitalResidency, Internal Medicine, 1994 - 1996
- Conemaugh Memorial Medical CenterInternship, Transitional Year, 1992 - 1993
- University Institute of Medicine 1Class of 1985
Certifications & Licensure
- TX State Medical License 1999 - 2026
- PA State Medical License 1993 - 2016
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib Start of enrollment: 2013 Jun 28
- Breast Cancer Index (BCI) Registry Start of enrollment: 2021 Apr 14
Publications & Presentations
PubMed
- 29 citationsRole of retinoid receptors in the prevention and treatment of breast cancer.Limin Yang, Caesar Tin-U, Kendall Wu, Powel H. Brown
Journal of Mammary Gland Biology and Neoplasia. 1999-01-01 - 30 citationsReceptor-selective retinoids inhibit the growth of normal and malignant breast cells by inducing G1 cell cycle blockade.Kendall Wu, Elizabeth DuPré, Heetae Kim, Caesar K. Tin-U, Reid P. Bissonnette
Breast Cancer Research and Treatment. 2006-03-01
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: